Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

HANSOH PHARMA

26.750
+0.3001.13%
Volume:2.76M
Turnover:73.64M
Market Cap:159.08B
PE:33.21
High:26.950
Open:26.500
Low:26.400
Close:26.450
Loading ...
OverviewCompanyNewsFilings

Concept

Hillhouse Capital Related-0.93%
Core Assets of Southward Funds-0.17%

Capital Flow

 
Inflow:
 
Outflow:
 
 
 
 
 
 
 
 
 
 
 
 
 
 

News

Hansoh Pharma's Aumolertinib Receives UK MHRA Approval for NSCLC Treatment, Marking First Overseas Launch of China-Developed EGFR-TKI

Reuters
·
Yesterday

BUZZ-Hansoh hits near 4-year peak as its cancer drug gets UK marketing approval

Reuters
·
04 Jun

Hansoh Pharmaceutical's Aumolertinib Mesilate Tablets Approved by UK MHRA for Marketing

Reuters
·
04 Jun

Hansoh Pharmaceutical - Aumolertinib Mesilate Tablets Was Approved by Mhra for Marketing

THOMSON REUTERS
·
04 Jun

Analyst Rate

Buy
Buy
95.23%
Hold
4.76%
Sell
0.00%

Corporate Actions

Ex-dividend Date
Jul 03, 2025 Dividend Per Share 0.1353 HKD
Financial Report Announcement
Mar 21, 2025 Post Market
Ex-dividend Date
Sep 20, 2024 Dividend Per Share 0.201 HKD
Financial Report Announcement
Aug 27, 2024 Post Market
Ex-dividend Date
Jun 19, 2024 Dividend Per Share 0.1422 HKD

Dividend History

Ex-DateDividend
2021-06-070.0771
2022-06-060.09
2022-09-080.05
2023-06-050.05
2023-09-070.0707

Valuation Analysis

32.95
Current
38.69
Sector Average
68.35%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
32.95
Maximum
90.60
+1 STD
58.82
Minimum
19.26
-1 STD
18.57
Average
38.69

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.